BackGenscript Biotech Overview

Genscript Biotech Inventory

Track Genscript Biotech's inventory ($45M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$45.23M
↑ 16.57% YoYΔ $6.43M vs prior year quarter

Peer trimmed avg / median

Loading

Genscript Biotech Inventory History

Loading

Genscript Biotech vs. peers: Inventory Comparison

Loading

Genscript Biotech Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genscript Biotech (GNNSF) FAQ

Genscript Biotech (GNNSF) currently reports a inventory of $45M as of June 2026. That compares with $39M in the prior-year period — up 16.6% year over year. Use the charts on this page to explore Genscript Biotech's inventory history and peer comparisons.

Genscript Biotech's inventory increased from $39M to $45M — a 16.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genscript Biotech reported $45M in inventory as of June 2026. That compares with $39M in the prior-year period — up 16.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genscript Biotech, and consider following GNNSF for alerts when major investors trade the stock.

Genscript Biotech is classified in the Healthcare sector. On inventory, it currently shows $45M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GNNSF with unrelated industries.